AFT new FDA approval could be a shot in the arm
Subscribe to BusinessDesk
Stay informed on business, government and financial developments across New Zealand.
- Deeply researched, twice-edited and fact-checked news
- Annual subscribers also receive a complimentary subscription to The Wall Street Journal
- Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers
You can cancel anytime with two clicks, an email or a phone call.
Find out
more.
We are serious about journalism.
All subscriptions auto renew but are easy to cancel.
Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}
Not convinced yet?
Subscribe to our free 7am Headlines newsletter.
A quick summary of everything BusinessDesk has published in the previous 24 hours. No BusinessDesk
subscription needed.
KMD Brands pulled into Trump trade war
Like a lot associated with so-called ‘Liberation Day’, much remains uncertain.
US tariff risk less than expected for FPH, Jarden says
Jarden says tariff-related impacts on earnings would be "nominal" by 2030.
Wall Street reels as Trump’s plan sinks markets
The president’s sweeping tariffs proved far more severe than investors predicted.
Commercial property trends: AI, sustainability and growing confidence
Falling rates and green tech shape property investment’s future.
